About: Unexpected SARS-CoV-2 cardiorespiratory arrest in a myopathy patient undergoing immunosuppressive treatment: A case report

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Unexpected SARS-CoV-2 cardiorespiratory arrest in a myopathy patient undergoing immunosuppressive treatment: A case report Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Unexpected SARS-CoV-2 cardiorespiratory arrest in a myopathy patient undergoing immunosuppressive treatment: A case report
Creator	Abpn, Colombo, Joe Depace, Nicholas Do, D Roshal, David Soloway, Alyxandra Soloway, Stephen
Source	Medline; PMC
abstract	RATIONALE: It is recommended that patients with Rheumatic diseases that are at high risk of developing active infections be screened for Tuberculosis, Hepatitis B, and Hepatitis C before receiving second-line immunosuppressive therapies. With the emergence 2019 novel coronavirus (SARS-CoV-2), expanded guidelines have not been proposed for screening in these patients before starting advanced therapy. PATIENT CONCERNS: We present an unique circumstance whereas a patient with a 5 year history of inflammatory muscle disease, diagnosed by clinical history and muscle biopsy with elevated creatine kinase levels, suffered a hypoxemic cardiopulmonary arrest due to asymptomatic SARS-CoV-2 after receiving advanced immunosuppressive therapy. DIAGNOSES: The patient presented with an acute exacerbation of inflammatory muscle disease with dysphagia, muscle weakness, and elevated creatine kinase. INTERVENTIONS: After no improvement with intravenous immunoglobulin the patient received mycophenolate and plasma exchange therapy. OUTCOMES: Subsequently the patient suffered a fatal hypoxemic cardiopulmonary arrest. Polymerase chain reaction test was positive for SARS-CoV-2 RNA. LESSONS: We conclude that rheumatic patients, asymptomatic for SARS-CoV-2 infection, be screened and tested before initiating second-line immunosuppressive treatment.
has issue date	2020-07-24(xsd:dateTime)
bibo:doi	10.1097/md.0000000000021377
bibo:pmid	32791748
has license	cc-by
sha1sum (hex)	2700f6dd8fc05723cb31bd16e42a3a7e0480e7a7
schema:url	https://doi.org/10.1097/md.0000000000021377
resource representing a document's title	Unexpected SARS-CoV-2 cardiorespiratory arrest in a myopathy patient undergoing immunosuppressive treatment: A case report
has PubMed Central identifier	PMC7386952
has PubMed identifier	32791748
schema:publication	Medicine (Baltimore)
resource representing a document's body	covid:2700f6dd8fc05723cb31bd16e42a3a7e0480e7a7#body_text
is schema:about of	named entity 'coronavirus' named entity 'therapies' named entity 'developing' named entity 'Tuberculosis' named entity 'screened' named entity 'Hepatitis C' named entity 'immunosuppressive' named entity 'Rheumatic diseases' named entity 'Hepatitis' named entity 'SARS-CoV-2' named entity 'Tuberculosis' named entity 'immunosuppressive treatment' named entity 'COVID-19' named entity 'SARS-CoV-2' named entity 'muscle strength' named entity 'intensive care unit' named entity 'mycophenolate' named entity 'Hypoxemia' named entity 'IVIG' named entity 'inflammatory response' named entity 'white blood cell count' named entity 'emergency room' named entity 'scleroderma' named entity 'fever' named entity 'coenzyme' named entity 'Euvolemic' named entity 'fatigue' named entity 'RNA' named entity 'asymptomatic' named entity 'inflammatory myopathies' named entity 'Furosemide' named entity 'dysphagia' named entity 'Rheumatological' named entity 'polymyositis' named entity 'mm Hg' named entity 'disease-modifying' named entity 'Synthetase' named entity 'first-line treatment' named entity 'systolic' named entity 'viral pneumonia' named entity 'inflammatory markers' named entity 'gene' named entity 'brain natriuretic peptide' named entity 'immunocompromised host' named entity 'Electrocardiogram' named entity 'hypertension' named entity 'methylprednisolone' named entity 'respirations' named entity 'assay' named entity 'Troponin' named entity 'precipitate' named entity 'second-line' named entity 'diastolic dysfunction' named entity '10.5' named entity 'COVID-19' named entity 'pulmonary infiltrate' named entity 'lupus' named entity 'acute coronary syndrome' named entity 'case report' named entity 'creatinine levels' named entity 'dysphagia' named entity '12.8' named entity 'pneumocystis pneumonia' named entity 'cardiopulmonary arrest' named entity 'dysphagia' named entity 'drink alcohol' named entity 'upper respiratory infection' named entity 'myositis' named entity 'inclusion body myositis' named entity 'intravenous' named entity 'fever' named entity 'malaise' named entity 'intensive care unit' named entity 'case report' named entity 'SARS-CoV-2'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software